Treatment of NCI-H441 and SK-MES-1 NSCLC cells with delphinidin (5-60 μM; 48 hrs) resulted in a significant reduction of cyclin D1 protein expression in a dose-dependent manner (Figure 2C). The gene discussed is CCND1; the disease is non-small cell lung carcinoma.